3 assets in Morton Neuroma

Therapeutic assets addressing Morton Neuroma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Acetylcysteine Morton Neuroma	University of Arizona	P2	CCC (53)
Lidocaine Morton Neuroma	Oregon Health and Science University	P1	CC (47)
Resiniferatoxin Morton Neuroma	National Institutes of Health Clinical Center (CC)	P1	CC (47)